Target intelligence / Profile preview

O-specific polysaccharide of Vibrio cholerae O1 Inaba lipopolysaccharide (OSP-Inaba)

Target
OSP-Inaba
Molecular classification
Polysaccharide, Bacterial antigen, Lipopolysaccharide component, Other
01

Overview

The O-specific polysaccharide (OSP) of Vibrio cholerae O1 Inaba is a critical surface antigen and a primary component of the lipopolysaccharide (LPS) found in the outer membrane of the bacterium (Chatterjee & Chaudhuri, 2003). It consists of a homopolymer of 4-amino-4-deoxy-D-mannose (perosamine) units linked by α(1→2) glycosidic bonds (Kasper et al., 1994). In the Inaba serotype, the terminal perosamine unit lacks the 2-O-methyl group found in the Ogawa serotype, a structural difference that defines its immunological specificity (Villeneuve et al., 2000). This molecule is the principal target for protective immunity against cholera, as antibodies directed against OSP are vibriocidal and can prevent the bacteria from colonizing the small intestine (Johnson et al., 2012). Consequently, OSP is a key component in both killed whole-cell oral cholera vaccines and experimental conjugate vaccines (Wierzba et al., 2015). Targeting this polysaccharide helps elicit a robust mucosal immune response, primarily through secretory IgA, which neutralizes the pathogen before it can cause the characteristic secretory diarrhea of cholera (Grandjean et al., 2016). The OSP-specific immune response is often measured via vibriocidal antibody titers, which serve as a surrogate marker for protection in clinical trials (Leung et al., 2004). Structural variations in OSP, such as those between Inaba and Ogawa, necessitate the inclusion of both serotypes in most vaccine formulations to ensure broad protection (Shin et al., 2011).

Other names
Vibrio cholerae O1 Inaba O-antigenInaba O-antigenV. cholerae O1 Inaba LPS O-chainInaba O-specific polysaccharide
02

Mechanism of action

Induction of protective vibriocidal antibodies and intestinal secretory IgA that prevent bacterial colonization and toxin production.

03

Biological functions

Immune response inductionBacterial virulencePathogen-host interactionSerotype specificity
04

Disease associations

CholeraInfection
05

Safety considerations

Serotype switching (Inaba to Ogawa)Limited immunogenicity in young childrenShort-term duration of immunity
06

Interacting drugs

Dukoral

4 more in the full profile.

07

Biomarkers

Vibriocidal antibody titerAnti-OSP IgA levelsAnti-OSP IgG levels

Beyond the preview

Go deeper on O-specific polysaccharide of Vibrio cholerae O1 Inaba lipopolysaccharide (OSP-Inaba).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-specific polysaccharide of Vibrio cholerae O1 Inaba lipopolysaccharide (OSP-Inaba).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call